Document is current
Any future updates will be listed below
-
Authors
Xing, Yue https://orcid.org/0000-0001-5845-2286
Reznikov, Ilana
Ahmed, Abonti Nur
Sidhu, Ikjot https://orcid.org/0000-0002-1470-6421
Wisnewski, Jill https://orcid.org/0000-0003-2976-3231
Farhat, Asma
Prystupa, Aleksandr
Konieczny, Piotr https://orcid.org/0000-0003-4114-349X
Mansfield, Kody
Cooper, Melissa L. https://orcid.org/0000-0003-4337-8356
Yeung, Stephen T. https://orcid.org/0000-0002-9710-5567
Kim, Madeline
Adeghe, Sophia
Gaines, Katherine D. https://orcid.org/0009-0005-8038-8870
Manson, Meredith
Sim, Ji Hyun
Huang, Qingrong https://orcid.org/0000-0002-7692-5160
Moshiri, Ata S. https://orcid.org/0000-0001-6684-4503
Khanna, Kamal M. https://orcid.org/0000-0002-9328-3817
Lu, Theresa T. https://orcid.org/0000-0002-5707-8744
Guttman-Yassky, Emma https://orcid.org/0000-0002-9363-324X
Lund, Amanda W. https://orcid.org/0000-0001-7389-9983
Anandasabapathy, Niroshana
Naik, Shruti https://orcid.org/0000-0002-2216-5135
- License Information
-
More Information
Article History
Received: 26 July 2024
Accepted: 19 January 2026
First Online: 25 February 2026
Competing interests
: S.N. is a cofounder of Stara Biosciences and receives funding from Leo Foundation and is a lecturer for Incyte and Abcam. N.A. serves on the SAB of Shennon Biosciences and Panther Life Sciences, and is a consultant or lecturer for Johnson and Johnson, Immunitas, 3T, 23&Me, Cellino, Kumquat, Verrica, Lytix and Genmab. E.G.-Y. is a consultant for AbbVie, Almirall, Amgen, AnaptysBio, Apogee Therapeutics, Apollo Therapeutics Limited, Artax Biopharma, AstraZeneca, Bristol Meyers Squibb, Boerhinger-Ingelhiem, Cara Therapeutics, Centrexion Therapeutics Corporation, Connect Biopharm, Eli Lilly, Enveda Biosciences, Escient Pharmaceuticals, Fairmount Funds Management, FL2022-001, Galderma, Gate Bio, Google Ventures, GSK Immunology, Horizon Therapeutics USA, Incyte, Inmagene, Janssen Biotech, Japan Tobacco, Jasper Therapeutics, Kyowa Kirin, Leo Pharma, Merck, Nektar Therapeutics, Novartis Pharmaceuticals, NUMAB Therapeutics AG, OrbiMed Advisors, OTSUKA Pfizer, Pharmaxis, Pioneering Medicine VII, Proteologix US, RAPT, Regeneron Pharmaceuticals, RibonTherapeutics, Sanofi, SATO, Schrödinger, Sun Pharma Advanced Research Company, Teva Branded Pharmaceutical Products R&D and UCB. A.W.L. reports consulting services for AGS Therapeutics. The other authors declare no competing interests.
